IQG — IQ Global Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
R2014 June 30th | 2015 June 30th | R2016 June 30th | 2017 June 30th | 2018 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.872 | 0.776 | 2.67 | 4.67 | 4.73 |
Cost of Revenue | |||||
Gross Profit | — | — | -0.001 | 0.833 | 0.006 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.28 | 4.88 | 9.61 | 13.7 | 20 |
Operating Profit | -1.41 | -4.1 | -6.94 | -9.06 | -15.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.41 | -4.37 | -7.39 | -10.2 | -15.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.41 | -4.37 | -7.39 | -9.88 | -14.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.41 | -4.37 | -6.61 | -9.24 | -13.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.41 | -4.37 | -6.61 | -9.24 | -13.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.011 | -0.035 | -0.065 | -0.076 | -0.099 |
Dividends per Share |